{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:25:44Z","timestamp":1787217944321,"version":"build-2736575974"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Ministero Italiano dell\u2019 Universit\u00e0 e della Ricerca","award":["PRIN 2022-Progetti di Rilevante Interesse Nazionale, project code: 2022ALJRPL"],"award-info":[{"award-number":["PRIN 2022-Progetti di Rilevante Interesse Nazionale, project code: 2022ALJRPL"]}]},{"DOI":"10.13039\/501100007514","name":"Universit\u00e0 di Pisa","doi-asserted-by":"publisher","award":["Proof-of-Concept (PoC) Spark Pisa 2025-grant, project \u201cTRIUMPH\u201d."],"award-info":[{"award-number":["Proof-of-Concept (PoC) Spark Pisa 2025-grant, project \u201cTRIUMPH\u201d."]}],"id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministero Italiano dell\u2019Universit\u00e0 e della Ricerca","award":["PRIN PNRR 2022-Progetti di Rilevante Interesse Nazionale P202252C7C"],"award-info":[{"award-number":["PRIN PNRR 2022-Progetti di Rilevante Interesse Nazionale P202252C7C"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"DOI":"10.1007\/s10534-026-00872-0","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:49:11Z","timestamp":1787215751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multifunctional auranofin analogues: dual-targeting TSPO\/TrxR gold(I) complexes with activity in resistant ovarian cancer"],"prefix":"10.1007","author":[{"given":"Lorenzo","family":"Chiaverini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Baglini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doralice","family":"Giorgini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Militello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Salerno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Viviano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Belvedere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"La Mendola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Da Settimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Gamberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iogann","family":"Tolbatov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Taliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"872_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12672-021-00439-0","volume":"12","author":"FH Abdalbari","year":"2021","unstructured":"Abdalbari FH, Telleria CM (2021) The gold complex auranofin: new perspectives for cancer therapy. Discov Oncol 12:1\u201318. https:\/\/doi.org\/10.1007\/s12672-021-00439-0","journal-title":"Discov Oncol"},{"key":"872_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12102973","volume":"12","author":"LM Ammer","year":"2020","unstructured":"Ammer LM, Vollmann-Zwerenz A, Ruf V et al (2020) The role of translocator protein TSPO in hallmarks of glioblastoma. Cancers (Basel) 12:1\u201326. https:\/\/doi.org\/10.3390\/cancers12102973","journal-title":"Cancers (Basel)"},{"key":"872_CR3","doi-asserted-by":"publisher","first-page":"12888","DOI":"10.1039\/d0sc04082g","volume":"11","author":"EJ Anthony","year":"2020","unstructured":"Anthony EJ, Bolitho EM, Bridgewater HE et al (2020) Metallodrugs are unique: opportunities and challenges of discovery and development. Chem Sci 11:12888\u201312917. https:\/\/doi.org\/10.1039\/d0sc04082g","journal-title":"Chem Sci"},{"key":"872_CR4","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1021\/acs.jctc.8b01176","volume":"15","author":"C Bannwarth","year":"2019","unstructured":"Bannwarth C, Ehlert S, Grimme S (2019) GFN2-xTB - an accurate and broadly parametrized self-consistent tight-binding quantum chemical method with multipole electrostatics and density-dependent dispersion contributions. J Chem Theory Comput 15:1652\u20131671. https:\/\/doi.org\/10.1021\/acs.jctc.8b01176","journal-title":"J Chem Theory Comput"},{"key":"872_CR5","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1021\/acs.jmedchem.5b00689","volume":"58","author":"E Barresi","year":"2015","unstructured":"Barresi E, Bruno A, Taliani S et al (2015) Deepening the topology of the translocator protein binding site by novel N,N-dialkyl-2-arylindol-3-ylglyoxylamides. J Med Chem 58:6081\u20136092. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00689","journal-title":"J Med Chem"},{"key":"872_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","volume":"155","author":"JS Berek","year":"2021","unstructured":"Berek JS, Renz M, Kehoe S et al (2021) Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet 155:61\u201385. https:\/\/doi.org\/10.1002\/ijgo.13878","journal-title":"Int J Gynaecol Obstet"},{"key":"872_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0162-0134(87)80081-8","volume":"31","author":"SJ Berners-Price","year":"1987","unstructured":"Berners-Price SJ, Sadler PJ (1987) Interaction of the antitumor Au(I) complex [Au(Ph2P(CH2)2PPh2)2]Cl with human blood plasma, red cells, and lipoproteins: 31P an. J Inorg Biochem 31:267\u2013281. https:\/\/doi.org\/10.1016\/0162-0134(87)80081-8","journal-title":"J Inorg Biochem"},{"key":"872_CR8","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1021\/ac9912247","volume":"72","author":"CD Bevan","year":"2000","unstructured":"Bevan CD, Lloyd RS (2000) A high-throughput screening method for the determination of aqueous drug solubility using laser nephelometry in microtiter plates. Anal Chem 72:1781\u20131787. https:\/\/doi.org\/10.1021\/ac9912247","journal-title":"Anal Chem"},{"key":"872_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drup.2010.12.002","volume":"14","author":"H Burger","year":"2011","unstructured":"Burger H, Loos WJ, Eechoute K et al (2011) Drug transporters of platinum-based anticancer agents and their clinical significance. Drug Resist Updat 14:22\u201334. https:\/\/doi.org\/10.1016\/j.drup.2010.12.002","journal-title":"Drug Resist Updat"},{"key":"872_CR10","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1021\/jm060436a","volume":"49","author":"A Casini","year":"2006","unstructured":"Casini A, Cinellu MA, Minghetti G et al (2006) Structural and solution chemistry, antiproliferative effects, and DNA and protein binding properties of a series of dinuclear gold(III) compounds with bipyridyl ligands. J Med Chem 49:5524\u20135531. https:\/\/doi.org\/10.1021\/jm060436a","journal-title":"J Med Chem"},{"key":"872_CR11","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1021\/jm201703k","volume":"55","author":"S Castellano","year":"2012","unstructured":"Castellano S, Taliani S, Milite C et al (2012) Synthesis and biological evaluation of 4-phenylquinazoline-2-carboxamides designed as a novel class of potent ligands of the translocator protein. J Med Chem 55:4506\u20134510. https:\/\/doi.org\/10.1021\/jm201703k","journal-title":"J Med Chem"},{"key":"872_CR12","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1021\/jm401721h","volume":"57","author":"S Castellano","year":"2014","unstructured":"Castellano S, Taliani S, Viviano M et al (2014) Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors. J Med Chem 57:2413\u20132428. https:\/\/doi.org\/10.1021\/jm401721h","journal-title":"J Med Chem"},{"key":"872_CR13","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1039\/b810189b","volume":"10","author":"JD Chai","year":"2008","unstructured":"Chai JD, Head-Gordon M (2008) Long-range corrected hybrid density functionals with damped atom-atom dispersion corrections. Phys Chem Chem Phys 10:6615\u20136620. https:\/\/doi.org\/10.1039\/b810189b","journal-title":"Phys Chem Chem Phys"},{"key":"872_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102294","volume":"52","author":"G Chiappetta","year":"2022","unstructured":"Chiappetta G, Gamberi T, Faienza F et al (2022) Redox proteome analysis of auranofin exposed ovarian cancer cells (A2780). Redox Biol 52:102294. https:\/\/doi.org\/10.1016\/j.redox.2022.102294","journal-title":"Redox Biol"},{"key":"872_CR15","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.3390\/MOLECULES27082578\/S1","volume":"27","author":"L Chiaverini","year":"2022","unstructured":"Chiaverini L, Pratesi A, Cirri D et al (2022) Anti-staphylococcal activity of the auranofin analogue bearing acetylcysteine in place of the thiosugar: an experimental and theoretical investigation. Molecules 27:2578. https:\/\/doi.org\/10.3390\/MOLECULES27082578\/S1","journal-title":"Molecules"},{"key":"872_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s10534-023-00496-8","volume":"36","author":"L Chiaverini","year":"2023","unstructured":"Chiaverini L, Baglini E, Mannelli M et al (2023) A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt3)]+ pharmacophore is highly cytotoxic against ovarian cancer cells. Biometals 36:961\u2013968. https:\/\/doi.org\/10.1007\/s10534-023-00496-8","journal-title":"Biometals"},{"key":"872_CR17","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s10534-019-00224-1","volume":"32","author":"D Cirri","year":"2019","unstructured":"Cirri D, Fabbrini MG, Massai L et al (2019) Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin. Biometals 32:939\u2013948. https:\/\/doi.org\/10.1007\/s10534-019-00224-1","journal-title":"Biometals"},{"key":"872_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/biomedicines9050504","volume":"9","author":"D Cirri","year":"2021","unstructured":"Cirri D, Bartoli F, Pratesi A et al (2021a) Strategies for the improvement of metal-based chemotherapeutic treatments. Biomedicines 9:504. https:\/\/doi.org\/10.3390\/biomedicines9050504","journal-title":"Biomedicines"},{"key":"872_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/biom11121858","volume":"11","author":"D Cirri","year":"2021","unstructured":"Cirri D, Marzo T, Tolbatov I et al (2021b) In vitro anti-SARS-CoV-2 activity of selected metal compounds and potential molecular basis for their actions based on computational study. Biomolecules 11:1858. https:\/\/doi.org\/10.3390\/biom11121858","journal-title":"Biomolecules"},{"key":"872_CR20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/02603594.2022.2152016","volume":"43","author":"D Cirri","year":"2023","unstructured":"Cirri D, Chiaverini L, Pratesi A, Marzo T (2023) Is the next cisplatin already in our laboratory? Comments Inorg Chem 43:465\u2013478. https:\/\/doi.org\/10.1080\/02603594.2022.2152016","journal-title":"Comments Inorg Chem"},{"key":"872_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.104822","volume":"87","author":"L Cosottini","year":"2023","unstructured":"Cosottini L, Massai L, Ghini V et al (2023) Bioconjugation of the gold drug auranofin to human ferritin yields a potent cytotoxin. J Drug Deliv Sci Technol 87:104822. https:\/\/doi.org\/10.1016\/j.jddst.2023.104822","journal-title":"J Drug Deliv Sci Technol"},{"key":"872_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep18164","volume":"6","author":"B Costa","year":"2016","unstructured":"Costa B, Da Pozzo E, Giacomelli C et al (2016) TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy. Sci Rep 6:18164. https:\/\/doi.org\/10.1038\/srep18164","journal-title":"Sci Rep"},{"key":"872_CR23","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1021\/jm8003224","volume":"51","author":"F Da Settimo","year":"2008","unstructured":"Da Settimo F, Simorini F, Taliani S et al (2008) Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis. J Med Chem 51:5798\u20135806. https:\/\/doi.org\/10.1021\/jm8003224","journal-title":"J Med Chem"},{"key":"872_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1021\/ic00328a028","volume":"29","author":"MM El-Etri","year":"1990","unstructured":"El-Etri MM, Scovell WM (1990) Synthesis and spectroscopic characterization of (triethylphosphine)gold(I) complexes AuX(PEt3) (X = Cl, Br, CN, SCN), [AuL(PEt3)+] (L = SMe2, SC(NH2)2, H2O), and (\u00b5-S)[Au(PEt3)]2. Inorg Chem 29:480\u2013484. https:\/\/doi.org\/10.1021\/ic00328a028","journal-title":"Inorg Chem"},{"key":"872_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1021\/acsptsci.9b00107","volume":"3","author":"BT Elie","year":"2020","unstructured":"Elie BT, Hubbard K, Layek B et al (2020) Auranofin-based analogues are effective against clear cell renal carcinoma in vivo and display no significant systemic toxicity. ACS Pharmacol Transl Sci 3:644\u2013654. https:\/\/doi.org\/10.1021\/acsptsci.9b00107","journal-title":"ACS Pharmacol Transl Sci"},{"key":"872_CR26","doi-asserted-by":"publisher","first-page":"13173","DOI":"10.1039\/c9nj02502b","volume":"43","author":"M Fereidoonnezhad","year":"2019","unstructured":"Fereidoonnezhad M, Ahmadi Mirsadeghi H, Abedanzadeh S et al (2019) Synthesis and biological evaluation of thiolate gold(i) complexes as thioredoxin reductase (TrxR) and glutathione reductase (GR) inhibitors. New J Chem 43:13173\u201313182. https:\/\/doi.org\/10.1039\/c9nj02502b","journal-title":"New J Chem"},{"key":"872_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2021.213905","volume":"438","author":"T Gamberi","year":"2021","unstructured":"Gamberi T, Pratesi A, Messori L, Massai L (2021) Proteomics as a tool to disclose the cellular and molecular mechanisms of selected anticancer gold compounds. Coord Chem Rev 438:213905. https:\/\/doi.org\/10.1016\/j.ccr.2021.213905","journal-title":"Coord Chem Rev"},{"key":"872_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cells13080661","volume":"13","author":"V Ghini","year":"2024","unstructured":"Ghini V, Sorbi F, Fambrini M, Magherini F (2024) NMR metabolomics of primary ovarian cancer cells in comparison to established cisplatin-resistant and -sensitive cell lines. Cells 13:661. https:\/\/doi.org\/10.3390\/cells13080661","journal-title":"Cells"},{"key":"872_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S (2019) Cisplatin: the first metal based anticancer drug. Bioorg Chem 88:102925. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102925","journal-title":"Bioorg Chem"},{"key":"872_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ph18111628","volume":"18","author":"D Giorgini","year":"2025","unstructured":"Giorgini D, Chiaverini L, Viviano M et al (2025) Repurposing Auranofin for oncology and beyond: a brief overview of clinical trials as mono- and combination therapy. Pharmaceuticals (Basel) 18:1628. https:\/\/doi.org\/10.3390\/ph18111628","journal-title":"Pharmaceuticals (Basel)"},{"key":"872_CR31","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1021\/acs.jctc.9b00143","volume":"15","author":"S Grimme","year":"2019","unstructured":"Grimme S (2019) Exploration of chemical compound, conformer, and reaction space with meta-dynamics simulations based on tight-binding quantum chemical calculations. J Chem Theory Comput 15:2847\u20132862. https:\/\/doi.org\/10.1021\/acs.jctc.9b00143","journal-title":"J Chem Theory Comput"},{"key":"872_CR32","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2967\/jnumed.116.178996","volume":"58","author":"M Ikawa","year":"2017","unstructured":"Ikawa M, Lohith TG, Shrestha S et al (2017) 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58:320\u2013325. https:\/\/doi.org\/10.2967\/jnumed.116.178996","journal-title":"J Nucl Med"},{"key":"872_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0020-1693(00)81848-4","volume":"91","author":"EM Kinsch","year":"1984","unstructured":"Kinsch EM, Stephan DW (1984) A 31P nuclear magnetic resonance and fluorescence study of the interaction of an anti-arthritic gold phosphine drug with albumin. A bioinorganic approach. Inorg Chim Acta 91:263\u2013267. https:\/\/doi.org\/10.1016\/S0020-1693(00)81848-4","journal-title":"Inorg Chim Acta"},{"key":"872_CR34","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1021\/acs.jctc.5b00601","volume":"11","author":"A Klamt","year":"2015","unstructured":"Klamt A, Moya C, Palomar J (2015) A comprehensive comparison of the IEFPCM and SS(V)PE continuum solvation methods with the COSMO approach. J Chem Theory Comput 11:4220\u20134225. https:\/\/doi.org\/10.1021\/acs.jctc.5b00601","journal-title":"J Chem Theory Comput"},{"key":"872_CR35","doi-asserted-by":"publisher","first-page":"96062","DOI":"10.18632\/oncotarget.21708","volume":"8","author":"I Landini","year":"2017","unstructured":"Landini I, Lapucci A, Pratesi A et al (2017) Selection and characterization of a human ovarian cancer cell line resistant to auranofin. Oncotarget 8:96062\u201396078. https:\/\/doi.org\/10.18632\/oncotarget.21708","journal-title":"Oncotarget"},{"key":"872_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/J.JINORGBIO.2020.111079","volume":"208","author":"I Landini","year":"2020","unstructured":"Landini I, Massai L, Cirri D et al (2020) Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties. J Inorg Biochem 208:111079. https:\/\/doi.org\/10.1016\/J.JINORGBIO.2020.111079","journal-title":"J Inorg Biochem"},{"key":"872_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1021\/cn3000108","volume":"3","author":"YS Lee","year":"2012","unstructured":"Lee YS, Sim\u00e9on FG, Briard E, Pike VW (2012) Solution structures of the prototypical 18 kDa translocator protein ligand, PK 11195, elucidated with 1H\/13C NMR spectroscopy and quantum chemistry. ACS Chem Neurosci 3:325\u2013335. https:\/\/doi.org\/10.1021\/cn3000108","journal-title":"ACS Chem Neurosci"},{"key":"872_CR38","doi-asserted-by":"publisher","DOI":"10.1021\/ACSMEDCHEMLETT.6C00118","author":"RD Leo","year":"2026","unstructured":"Leo RD, Crispino E, Chiaverini L et al (2026) A dual-action gold(I) prodrug targeting redox homeostasis and extracellular matrix remodeling in ovarian cancer. ACS Med Chem Lett. https:\/\/doi.org\/10.1021\/ACSMEDCHEMLETT.6C00118","journal-title":"ACS Med Chem Lett"},{"key":"872_CR39","doi-asserted-by":"publisher","first-page":"15719","DOI":"10.1021\/jacs.5c03186","volume":"147","author":"M Liu","year":"2025","unstructured":"Liu M, Liu H, Yang Y et al (2025) Subcellular photocatalysis enables tumor-targeted inhibition of thioredoxin reductase I by organogold(I) complexes. J Am Chem Soc 147:15719\u201315731. https:\/\/doi.org\/10.1021\/jacs.5c03186","journal-title":"J Am Chem Soc"},{"key":"872_CR40","doi-asserted-by":"publisher","first-page":"5518","DOI":"10.1039\/D1CS00933H","volume":"51","author":"Y Lu","year":"2022","unstructured":"Lu Y, Ma X, Chang X et al (2022) Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases. Chem Soc Rev 51:5518\u20135556. https:\/\/doi.org\/10.1039\/D1CS00933H","journal-title":"Chem Soc Rev"},{"key":"872_CR41","doi-asserted-by":"publisher","first-page":"14896","DOI":"10.1039\/c5dt01196e","volume":"44","author":"T Marzo","year":"2015","unstructured":"Marzo T, Pillozzi S, Hrabina O et al (2015) Cis-Pt I2(NH3)2: a reappraisal. Dalton Trans 44:14896\u201314905. https:\/\/doi.org\/10.1039\/c5dt01196e","journal-title":"Dalton Trans"},{"key":"872_CR42","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/acsmedchemlett.7b00162","volume":"8","author":"T Marzo","year":"2017","unstructured":"Marzo T, Cirri D, Gabbiani C et al (2017) Auranofin, Et3PAuCl, and Et3PAuI are highly cytotoxic on colorectal cancer cells: a chemical and biological study. ACS Med Chem Lett 8:997\u20131001. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00162","journal-title":"ACS Med Chem Lett"},{"key":"872_CR43","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/acsmedchemlett.9b00007","volume":"10","author":"T Marzo","year":"2019","unstructured":"Marzo T, Massai L, Pratesi A et al (2019) Replacement of the thiosugar of auranofin with iodide enhances the anticancer potency in a mouse model of ovarian cancer. ACS Med Chem Lett 10:656\u2013660. https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00007","journal-title":"ACS Med Chem Lett"},{"key":"872_CR44","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1021\/jm001004h","volume":"44","author":"M Matarrese","year":"2001","unstructured":"Matarrese M, Moresco RM, Cappelli A et al (2001) Labeling and evaluation of N-[11C]methylated quinoline-2-carboxamides as potential radioligands for visualization of peripheral benzodiazepine receptors. J Med Chem 44:579\u2013585. https:\/\/doi.org\/10.1021\/jm001004h","journal-title":"J Med Chem"},{"key":"872_CR45","doi-asserted-by":"publisher","first-page":"10100","DOI":"10.1039\/c3cc46400h","volume":"49","author":"L Messori","year":"2013","unstructured":"Messori L, Scaletti F, Massai L et al (2013) The mode of action of anticancer gold-based drugs: a structural perspective. Chem Commun 49:10100\u201310102. https:\/\/doi.org\/10.1039\/c3cc46400h","journal-title":"Chem Commun"},{"key":"872_CR46","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1021\/acs.jmedchem.7b01031","volume":"60","author":"C Milite","year":"2017","unstructured":"Milite C, Barresi E, Da Pozzo E et al (2017) Exploiting the 4-phenylquinazoline scaffold for the development of high affinity fluorescent probes for the translocator protein (TSPO). J Med Chem 60:7897\u20137909. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01031","journal-title":"J Med Chem"},{"key":"872_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202218000","volume":"62","author":"G Moreno-Alc\u00e1ntar","year":"2023","unstructured":"Moreno-Alc\u00e1ntar G, Picchetti P, Casini A (2023) Gold complexes in anticancer therapy: from new design principles to particle-based delivery systems. Angew Chem Int Ed Engl 62:e202218000. https:\/\/doi.org\/10.1002\/anie.202218000","journal-title":"Angew Chem Int Ed Engl"},{"key":"872_CR49","doi-asserted-by":"publisher","first-page":"10507","DOI":"10.1021\/acs.inorgchem.8b02177","volume":"57","author":"A Pratesi","year":"2018","unstructured":"Pratesi A, Cirri D, Ciofi L, Messori L (2018) Reactions of auranofin and its pseudohalide derivatives with serum albumin investigated through ESI-Q-TOF MS. Inorg Chem 57:10507\u201310510. https:\/\/doi.org\/10.1021\/acs.inorgchem.8b02177","journal-title":"Inorg Chem"},{"key":"872_CR50","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1021\/jm030973k","volume":"47","author":"G Primofiore","year":"2004","unstructured":"Primofiore G, Da Settimo F, Taliani S et al (2004) N,N-Dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral renzodiazepine receptor. J Med Chem 47:1852\u20131855. https:\/\/doi.org\/10.1021\/jm030973k","journal-title":"J Med Chem"},{"key":"872_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","volume":"15","author":"C Roder","year":"2015","unstructured":"Roder C, Thomson MJ (2015) Auranofin: repurposing an old drug for a golden new age. Drugs R D 15:13\u201320. https:\/\/doi.org\/10.1007\/s40268-015-0083-y","journal-title":"Drugs R D"},{"key":"872_CR100","doi-asserted-by":"publisher","unstructured":"Ronga L, Tolbatov I, Giorgi E et al (2023) Mechanistic evaluations of the effects of auranofin triethylphosphine replacement with a trimethylphosphite moiety. Inorg Chem 62:10389\u201310396. https:\/\/doi.org\/10.1021\/acs.inorgchem.3c01280","DOI":"10.1021\/acs.inorgchem.3c01280"},{"key":"872_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29174212","volume":"29","author":"S Salerno","year":"2024","unstructured":"Salerno S, Viviano M, Baglini E et al (2024) TSPO radioligands for neuroinflammation: an overview. Molecules 29:4212. https:\/\/doi.org\/10.3390\/molecules29174212","journal-title":"Molecules"},{"key":"872_CR53","doi-asserted-by":"publisher","first-page":"9533","DOI":"10.1073\/pnas.171178698","volume":"98","author":"T Sandalova","year":"2001","unstructured":"Sandalova T, Zhong L, Lindqvist Y et al (2001) Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci U S A 98:9533\u20139538. https:\/\/doi.org\/10.1073\/pnas.171178698","journal-title":"Proc Natl Acad Sci U S A"},{"key":"872_CR54","doi-asserted-by":"publisher","first-page":"13769","DOI":"10.1074\/jbc.M114.549634","volume":"289","author":"J \u0160ileikyte","year":"2014","unstructured":"\u0160ileikyte J, Blachly-Dyson E, Sewell R et al (2014) Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (translocator protein of 18 kDa (TSPO)). J Biol Chem 289:13769\u201313781. https:\/\/doi.org\/10.1074\/jbc.M114.549634","journal-title":"J Biol Chem"},{"key":"872_CR55","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf7444","volume":"10","author":"WC Stafford","year":"2018","unstructured":"Stafford WC, Peng X, Olofsson MH et al (2018) Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy. Sci Transl Med 10:eaaf7444. https:\/\/doi.org\/10.1126\/scitranslmed.aaf7444","journal-title":"Sci Transl Med"},{"key":"872_CR56","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1515\/9783110470734-019","volume":"18","author":"MP Sullivan","year":"2018","unstructured":"Sullivan MP, Holtkamp HU, Hartinger CG (2018) Antitumor metallodrugs that target proteins. Met Ions Life Sci 18:351\u2013386. https:\/\/doi.org\/10.1515\/9783110470734-019","journal-title":"Met Ions Life Sci"},{"key":"872_CR57","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1021\/jm00281a001","volume":"15","author":"BM Sutton","year":"1972","unstructured":"Sutton BM, Mcgusty E, Walz DT, Dimartino MJ (1972) Oral gold. Antiarthritic properties of alkylphosphinegold coordination complexes. J Med Chem 15:1095\u20131098. https:\/\/doi.org\/10.1021\/jm00281a001","journal-title":"J Med Chem"},{"key":"872_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep22571","volume":"6","author":"S Thangamani","year":"2016","unstructured":"Thangamani S, Mohammad H, Abushahba MFN et al (2016) Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens. Sci Rep 6:1\u201313. https:\/\/doi.org\/10.1038\/srep22571","journal-title":"Sci Rep"},{"key":"872_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/chem.202502606","volume":"31","author":"I Tolbatov","year":"2025","unstructured":"Tolbatov I, Marrone A (2025) Dual biomolecule recognition by diruthenium paddlewheel complexes: a combined computational thermodynamics and bioinformatic structural analysis. Chem Eur J 31:e02606. https:\/\/doi.org\/10.1002\/chem.202502606","journal-title":"Chem Eur J"},{"key":"872_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2025.113161","volume":"276","author":"I Tolbatov","year":"2026","unstructured":"Tolbatov I, Marrone A (2026) Combined computational and bioinformatic approach to uncover the pre-covalent protein interactions of auranofin and its chlorido derivative Au(Pet3)Cl. J Inorg Biochem 276:113161. https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113161","journal-title":"J Inorg Biochem"},{"key":"872_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00812","volume":"8","author":"I Tolbatov","year":"2020","unstructured":"Tolbatov I, Cirri D, Marchetti L et al (2020) Mechanistic insights into the anticancer properties of the auranofin analog Au(PEt3)I: a theoretical and experimental study. Front Chem 8:812. https:\/\/doi.org\/10.3389\/fchem.2020.00812","journal-title":"Front Chem"},{"key":"872_CR62","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1039\/d4dt02621g","volume":"54","author":"I Tolbatov","year":"2024","unstructured":"Tolbatov I, Marzo T, Umari P et al (2024a) Detailed mechanism of a DNA\/RNA nucleobase substituting bridging ligand in diruthenium(ii,iii) and dirhodium(ii,ii) tetraacetato paddlewheel complexes: protonation of the leaving acetate is crucial. Dalt Trans 54:662\u2013673. https:\/\/doi.org\/10.1039\/d4dt02621g","journal-title":"Dalt Trans"},{"key":"872_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2024.108806","volume":"131","author":"I Tolbatov","year":"2024","unstructured":"Tolbatov I, Umari P, Marrone A (2024b) The binding of diruthenium (II,III) and dirhodium (II,II) paddlewheel complexes at DNA\/RNA nucleobases: computational evidences of an appreciable selectivity toward the AU base pairs. J Mol Graph Model 131:108806. https:\/\/doi.org\/10.1016\/j.jmgm.2024.108806","journal-title":"J Mol Graph Model"},{"key":"872_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-1280(98)00553-3","author":"J Tomasi","year":"1999","unstructured":"Tomasi J, Mennucci B, Canc\u00e8s E (1999) The IEF version of the PCM solvation method: an overview of a new method addressed to study molecular solutes at the QM ab initio level. J Mol Struct THEOCHEM. https:\/\/doi.org\/10.1016\/S0166-1280(98)00553-3","journal-title":"J Mol Struct THEOCHEM"},{"key":"872_CR48","unstructured":"University of Kansas Medical Centre (2016) Phase I and II study of Auranofin in chronic lymphocytic leukemia (CLL). In: ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT01419691. Accessed 26 May 2026"},{"key":"872_CR65","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/17460441.2024.2355329","volume":"19","author":"V Vitali","year":"2024","unstructured":"Vitali V, Massai L, Messori L (2024) Strategies for the design of analogs of auranofin endowed with anticancer potential. Expert Opin Drug Discov 19:855\u2013867. https:\/\/doi.org\/10.1080\/17460441.2024.2355329","journal-title":"Expert Opin Drug Discov"},{"key":"872_CR66","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1039\/d5qi01487e","volume":"13","author":"V Vitali","year":"2026","unstructured":"Vitali V, Chiaverini L, Severi M et al (2026) The impact of albumin conjugation on the cytotoxic properties of cisplatin, oxaliplatin and auranofin in cancer cells. Inorg Chem Front 13:106\u2013111. https:\/\/doi.org\/10.1039\/d5qi01487e","journal-title":"Inorg Chem Front"},{"key":"872_CR67","doi-asserted-by":"publisher","first-page":"4862","DOI":"10.2174\/0929867329666220329204054","volume":"29","author":"M Viviano","year":"2022","unstructured":"Viviano M, Barresi E, Sim\u00e9on FG et al (2022) Essential principles and recent progress in the development of TSPO PET ligands for neuroinflammation imaging. Curr Med Chem 29:4862\u20134890. https:\/\/doi.org\/10.2174\/0929867329666220329204054","journal-title":"Curr Med Chem"},{"key":"872_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62634-9","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Cao B, Wang Q et al (2025) Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation. Nat Commun 16:7347-. https:\/\/doi.org\/10.1038\/s41467-025-62634-9","journal-title":"Nat Commun"},{"key":"872_CR69","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1039\/b508541a","volume":"7","author":"F Weigend","year":"2005","unstructured":"Weigend F, Ahlrichs R (2005) Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: design and assessment of accuracy. Phys Chem Chem Phys 7:3297\u20133305. https:\/\/doi.org\/10.1039\/b508541a","journal-title":"Phys Chem Chem Phys"},{"key":"872_CR70","doi-asserted-by":"publisher","first-page":"7751","DOI":"10.1021\/acs.jmedchem.9b00550","volume":"62","author":"B Wu","year":"2019","unstructured":"Wu B, Yang X, Yan M (2019) Synthesis and structure-activity relationship study of antimicrobial auranofin against ESKAPE pathogens. J Med Chem 62:7751\u20137768. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00550","journal-title":"J Med Chem"},{"key":"872_CR71","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1021\/jacs.4c15820","volume":"147","author":"K Xiao","year":"2025","unstructured":"Xiao K, Hou DY, Zhang NY et al (2025) Synergistic enhancement of ferroptosis via mitochondrial accumulation and photodynamic-controlled release of an organogold(I) cluster prodrug. J Am Chem Soc 147:4482\u20134492. https:\/\/doi.org\/10.1021\/jacs.4c15820","journal-title":"J Am Chem Soc"},{"key":"872_CR72","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1021\/cn500138n","volume":"5","author":"P Zanotti-Fregonara","year":"2014","unstructured":"Zanotti-Fregonara P, Zhang Y, Jenko KJ et al (2014) Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971. ACS Chem Neurosci 5:963\u2013971. https:\/\/doi.org\/10.1021\/cn500138n","journal-title":"ACS Chem Neurosci"},{"key":"872_CR73","doi-asserted-by":"publisher","first-page":"5906","DOI":"10.1039\/d0dt00283f","volume":"49","author":"C Zoppi","year":"2020","unstructured":"Zoppi C, Messori L, Pratesi A (2020) ESI MS studies highlight the selective interaction of Auranofin with protein free thiols. Dalt Trans 49:5906\u20135913. https:\/\/doi.org\/10.1039\/d0dt00283f","journal-title":"Dalt Trans"},{"key":"872_CR99","doi-asserted-by":"publisher","unstructured":"Zou T, Lum CT, Lok CN et al (2015) Chemical biology of anticancer gold(III) and gold(i) complexes. Chem Soc Rev 44:8786\u20138801. https:\/\/doi.org\/10.1039\/c5cs00132c","DOI":"10.1039\/c5cs00132c"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-026-00872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10534-026-00872-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-026-00872-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T08:49:14Z","timestamp":1787215754000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10534-026-00872-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":75,"alternative-id":["872"],"URL":"https:\/\/doi.org\/10.1007\/s10534-026-00872-0","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interest. No unexpected or unusually high safety hazards were encountered in the reported experiments. The Human plasma used in this study (\n                      31\n                      P NMR RDL-15 stability experiments) was purchased commercially (Sigma-Aldrich) and was fully anonymized, therefore, no institutional ethical approval was required.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}